Profile data is unavailable for this security.
About the company
PT Enseval Putera Megatrading Tbk is an Indonesia-based integrated distribution and logistics service company in the health sector. The Company is engaged in the distribution and supply of pharmaceutical products, consumer products, medical equipment, cosmetics and other trading products. Its business activities include the distribution and sale of consumer products; prescription medicines; non-prescription medicines; raw materials for sale; medical equipment; veterinary and livestock medicines; and healthcare and transportation services. It provides services across digital platforms, distribution and sales, healthcare, marketing, and logistics. It offers a range of products, such as consumer products, prescription and non-prescription medicines, raw materials, medical devices, clinics and veterinary products.
- Revenue in IDR (TTM)32.20tn
- Net income in IDR758.02bn
- Incorporated1989
- Employees5.08k
- LocationEnseval Putera Megatrading Tbk PTJl. Pulo Lentut No. 10Kawasan Industri Pulo GadungJAKARTA TIMUR 13920IndonesiaIDN
- Phone+62 2 146822422
- Fax+62 214609039
- Websitehttps://www.enseval.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Zhejiang East Asia Pharmaceutical Co Ltd | 2.03tn | -531.65bn | 6.07tn | 1.75k | -- | 1.37 | -- | 3.00 | -1.97 | -1.97 | 7.34 | 15.80 | 0.2409 | 0.8634 | 5.60 | 475,447.80 | -6.33 | 2.47 | -8.09 | 3.12 | 25.78 | 24.66 | -26.25 | 5.78 | 0.7513 | -411.46 | 0.3533 | 42.92 | -11.66 | 3.93 | -183.02 | -- | 29.64 | -- |
| Niox Group PLC | 1.06tn | 112.56bn | 6.09tn | 84.00 | 55.42 | 4.11 | 29.12 | 5.76 | 0.0114 | 0.0122 | 0.1096 | 0.1542 | 0.5804 | 3.28 | 8.85 | 547,619.10 | 6.18 | 0.4655 | 6.66 | 0.5113 | 71.09 | 70.62 | 10.65 | 1.55 | 3.07 | -- | 0.0183 | 788.00 | 13.59 | 3.85 | -64.21 | -- | -37.28 | -- |
| Fuji Pharma Co Ltd | 6.01tn | 257.13bn | 6.17tn | 1.76k | 23.57 | 1.15 | 8.90 | 1.03 | 95.46 | 95.46 | 2,233.29 | 1,959.48 | 0.5765 | 1.49 | 2.83 | 31,007,950.00 | 2.46 | 4.51 | 3.93 | 6.76 | 40.82 | 40.57 | 4.27 | 8.51 | 0.876 | 17.58 | 0.3885 | 25.98 | 12.01 | 8.87 | -51.19 | 7.55 | 8.07 | 7.94 |
| Enseval Putera Megatrading Tbk PT | 32.20tn | 758.02bn | 6.20tn | 5.08k | 8.18 | 0.8107 | 6.53 | 0.1926 | 279.85 | 279.85 | 11,888.59 | 2,824.64 | 2.74 | 7.42 | 6.71 | 6,386,735,000.00 | 6.44 | 7.53 | 9.91 | 10.81 | 10.07 | 10.47 | 2.35 | 2.80 | 1.46 | 38.64 | 0.0038 | 67.96 | 8.59 | 6.85 | 7.74 | 5.02 | -7.51 | 14.74 |
| Orchid Pharma Ltd | 1.53tn | 97.12bn | 6.26tn | 737.00 | 64.46 | 2.65 | 38.74 | 4.10 | 10.31 | 10.31 | 162.05 | 251.16 | 0.4893 | 1.58 | 3.94 | 11,143,480.00 | 3.10 | 1.40 | 3.63 | 1.72 | 39.83 | 35.89 | 6.33 | 2.75 | 1.90 | 2.18 | 0.181 | -- | 12.48 | 13.76 | 8.13 | -- | 104.06 | -- |
| Aarti Drugs Ltd | 4.69tn | 376.52bn | 6.31tn | 1.28k | 16.84 | -- | 12.74 | 1.35 | 22.07 | 22.07 | 274.99 | -- | -- | -- | -- | 19,639,960.00 | -- | 9.09 | -- | 14.39 | 36.35 | 22.09 | 8.03 | 8.08 | -- | 7.00 | -- | 6.07 | -5.60 | 5.74 | -1.90 | 3.53 | 29.85 | 14.87 |
| Gujarat Themis Biosyn Ltd | 296.11bn | 88.82bn | 6.32tn | 221.00 | 71.20 | -- | 58.78 | 21.36 | 4.39 | 4.39 | 14.62 | -- | -- | -- | -- | 7,209,322.00 | -- | 30.70 | -- | 34.37 | 62.78 | 68.03 | 29.99 | 35.51 | -- | 55.73 | -- | -- | -11.20 | 12.12 | -17.56 | 15.55 | 104.61 | 24.95 |
| Clinuvel Pharmaceuticals Ltd | 1.13tn | 430.71bn | 6.34tn | 16.00 | 14.77 | 2.21 | 14.25 | 5.60 | 0.7177 | 0.7177 | 1.89 | 4.80 | 0.3779 | 0.1857 | 3.54 | -- | 14.39 | 17.33 | 16.06 | 19.40 | 98.10 | 101.95 | 38.07 | 38.23 | 9.34 | -- | 0.0022 | 7.22 | -0.5085 | 23.46 | 1.50 | 19.17 | -19.60 | 14.87 |
